Self-reported skin diseases, quality of life and medication use: A nationwide pharmaco-epidemiological survey in Sweden

Acta Dermato-Venereologica

Volumn 94, Issue 2, 2014, Pages 188-191

  Lindberg, Magnus ^a   Isacson, Dag ^b   Bingefors, Kerstin ^b  

^a ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Dermatological agents; Pharmacoepidemiology; Quality of life; Skin diseases

Indexed keywords

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DERMATOLOGIC AGENTS; FEMALE; GLUCOCORTICOIDS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PHYTOTHERAPY; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SKIN DISEASES; SWEDEN; YOUNG ADULT;

EID: 84894105324     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1672     Document Type: Article

References (52)

1. Schofield JK, Fleming D, Grindlay D, Williams H. Skin conditions are the commonest new reason people present to general practitioners in England and Wales. Br J Dermatol 2011; 165: 1044-1050.
2. Rea JN, Newhouse ML, Halil T. Skin disease in Lambeth. A community study of prevalence and use of medical care. Br J Prev Soc Med 1976; 30: 107-114.
3. Augustin M, Herberger K, Hintzen S, Heigel H, Franzke N, Schafer I. Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers. Br J Dermatol 2011; 165: 865-873.
4. Bingefors K, Lindberg M, Isacson D. Self-reported dermatological problems and use of prescribed topical drugs correlate with decreased quality of life: an epidemiological survey. Br J Dermatol 2002; 147: 285-290.
5. Jagou M, Bastuji-Garin S, Bourdon-Lanoy E, Penso- Assathiany D, Roujeau JC, Reseau d'Epidemiologie en D. Poor agreement between self-reported and dermatologists' diagnoses for five common dermatoses. Br J Dermatol 2006; 155: 1006-1012.
6. Meding B, Barregard L. Validity of self-reports of hand eczema. Contact Dermatitis 2001; 45: 99-103.
7. Kalia S, Haiducu ML. The burden of skin disease in the United States and Canada. Dermatol Clin 2012; 30: 5-18, vii.
8. Finlay AY. The burden of skin disease: quality of life, economic aspects and social issues. Clin Med 2009; 9: 592-594.
9. Basra MK, Shahrukh M. Burden of skin diseases. Expert Rev Pharmacoecon Outcomes Res 2009; 9: 271-283.
10. Smith JG, Jr. Burden of skin disease. J Am Acad Dermatol 2007; 56: 706.
11. Chen SC, Bayoumi AM, Soon SL, Aftergut K, Cruz P, Sexton SA, McCall CO, et al. A catalog of dermatology utilities: a measure of the burden of skin diseases. J Invest Dermatol Symp Proc 2004; 9: 160-168.
12. Dalgard F, Svensson A, Holm JO, Sundby J. Self-reported skin morbidity in Oslo. Associations with sociodemographic factors among adults in a cross-sectional study. Br J Dermatol 2004; 151: 452-457.
13. Bingefors K, Lindberg M, Isacson D. Quality of life, use of topical medications and socio-economic data in hand eczema: a Swedish nationwide survey. Acta Derm Venereol 2011; 91: 452-458.
14. Hald M, Agner T, Blands J, Johansen JD. Quality of life in a population of patients with hand eczema: a six-month follow-up study. Acta Derm Venereol 2011; 91: 484-486.
15. Bingefors K, Svensson A, Isacson D, Lindberg M. Self- reported life-time prevalence of atopic dermatitis and co-morbidity with asthma and eczema in adulthood. A population-based cross-sectional survey. Acta Derm Venereol 2013; 93: 438-441.
16. Sweden S. [Survey on health, report on a survey conducted November 2004-January 2005]. 2005 (in Swedish).
17. Lundström S, Särndal CE. Calibration as a standard method for treatment of nonresponse. J Offical Stat 1999; 15: 305-327.
18. Ware JE, Kosinski M, Sherbourne CA. SF-36 Physical and Mental Health Summary Scales: a user's manual. Boston, MA: New England Medical Center, 1994.
19. Ware JE, Snow KK, Kosinski M, Sherbourne CA. SF-36 Health survey manual and interpretation guide. Boston, MA: New England Medical Center, 1993.
20. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
21. Stenberg B, Lindberg M, Meding B, Svensson A. Is the question 'Have you had childhood eczema?' useful for assessing childhood atopic eczema in adult population surveys? Contact Dermatitis 2006; 54: 334-337.
22. Inc. SI. The SAS System for Windows, Release 8.02 [1999-2001]. Cary, NC: SAS Institute Inc., 2001.
23. Moberg C, Meding B, Stenberg B, Svensson A, Lindberg M. Remembering childhood atopic dermatitis as an adult: factors that influence recollection. Br J Dermatol 2006; 155: 557-560.
24. Cashman MW, Reutemann PA, Ehrlich A. Contact dermatitis in the United States: epidemiology, economic impact, and workplace prevention. Dermatol Clin 2012; 30: 87-98, viii.
25. Schaefer I, Rustenbach SJ, Zimmer L, Augustin M. Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology 2008; 217: 169-172.
26. Meding B, Liden C, Berglind N. Self-diagnosed dermatitis in adults. Results from a population survey in Stockholm. Contact Dermatitis 2001; 45: 341-345.
27. Stenberg B, Meding B, Svensson A. Dermatology in public health- a model for surveillance of common skin diseases. Scand J Public Health 2010; 38: 368-374.
28. Thyssen JP, Johansen JD, Linneberg A, Menne T. The epidemiology of hand eczema in the general population- -prevalence and main findings. Contact Dermatitis 2010; 62: 75-87.
29. Lomholt G. Prevalence of Skin Diseases in a Population; a Census Study from the Faroe Islands. Dan Med Bull 1964; 11: 1-7.
30. Larsson PA, Liden S. Prevalence of skin diseases among adolescents 12-16 years of age. Acta Derm Venereol 1980; 60: 415-423.
31. Braathen LR, Botten G, Bjerkedal T. Psoriatics in Norway. A questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Derm Venereol Suppl 1989; 142: 9-12.
32. Schafer I, Rustenbach SJ, Radtke M, Augustin J, Glaeske G, Augustin M. Epidemiologie der Psoriasis in Deutschland - Auswertung von Sekundärdaten einer gesetzlichen Kran- kenversicherung. Gesundheitswesen 2011; 73: 308-313.
33. Moberg C, Alderling M, Meding B. Hand eczema and quality of life: a population-based study. Br J Dermatol 2009; 161: 397-403.
34. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol 2011; 131: 67-73.
35. Wolkewitz M, Rothenbacher D, Low M, Stegmaier C, Ziegler H, Radulescu M, Brenner H, et al. Lifetime prevalence of self-reported atopic diseases in a population-based sample of elderly subjects: results of the ESTHER study. Br J Dermatol 2007; 156: 693-697.
36. Harrop J, Chinn S, Verlato G, Olivieri M, Norback D, Wjst M, Janson C, et al. Eczema, atopy and allergen exposure in adults: a population-based study. Clin Exp Allergy 2007; 37: 526-535.
37. Hanifin JM, Reed ML, Eczema P, Impact Working G. A population-based survey of eczema prevalence in the United States. Dermatitis 2007; 18: 82-91.
38. Yentzer BA, Hick J, Reese EL, Uhas A, Feldman SR, Balkrishnan R. Acne vulgaris in the United States: a descriptive epidemiology. Cutis 2010; 86: 94-99.
39. Perkins AC, Cheng CE, Hillebrand GG, Miyamoto K, Kimball AB. Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women. J Eur Acad Dermatol Venereol 2011; 25: 1054-1060.
40. Halvorsen JA, Vleugels RA, Bjertness E, Lien L. A population-based study of acne and body mass index in adolescents. Arch Dermatol 2012; 148: 131-132.
41. Breunig Jde A, de Almeida HL Jr, Duquia RP, Souza PR, Acta Derm Venereol 94 Staub HL. Scalp seborrheic dermatitis: prevalence and associated factors in male adolescents. Int J Dermatol 2012; 51: 46-49.
42. Sampogna F, Tabolli S, Soderfeldt B, Axtelius B, Aparo U, Abeni D, investigators IDIMPRoVE. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol 2006; 154: 844-849.
43. Heydendael VM, de Borgie CA, Spuls PI, Bossuyt PM, Bos JD, de Rie MA. The burden of psoriasis is not determined by disease severity only. J Invest Dermatol Symp Proc 2004; 9: 131-135.
44. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 2000; 80: 430-434.
45. Agner T, Andersen KE, Brandao FM, Bruynzeel DP, Bruze M, Frosch P, Goncalo M, et al. Hand eczema severity and quality of life: a cross-sectional, multicentre study of hand eczema patients. Contact Dermatitis 2008; 59: 43-47.
46. Cvetkovski RS, Zachariae R, Jensen H, Olsen J, Johansen JD, Agner T. Quality of life and depression in a population of occupational hand eczema patients. Contact Dermatitis 2006; 54: 106-111.
47. Meding B, Swanbeck G. Consequences of having hand eczema. Contact Dermatitis 1990; 23: 6-14.
48. Wallenhammar LM, Nyfjall M, Lindberg M, Meding B. Health-related quality of life and hand eczema - a comparison of two instruments, including factor analysis. J Invest Dermatol 2004; 122: 1381-1389.
49. Maksimovic N, Jankovic S, Marinkovic J, Sekulovic LK, Zivkovic Z, Spiric VT. Health-related quality of life in patients with atopic dermatitis. J Dermatol 2012; 39: 42-47.
50. Demircay Z, Seckin D, Senol A, Demir F. Patient's perspective: an important issue not to be overlooked in assessing acne severity. Eur J Dermatol 2008; 18: 181-184.
51. Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140: 672-676.
52. O'Neill P, Kelly P. Postal questionnaire study of disability in the community associated with psoriasis. BMJ 1996; 313: 919-921.